Farther Finance Advisors’s Palvella Therapeutics PVLA Stock Holding History

Farther Finance Advisors’s Portfolio PVLA Stock Details PVLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.99K	Buy	13 +10	+333%	+$1.21K	﹤0.01%	5171
2026 Q1	$361	Sell	3 -16	-84%	-$1.67K	﹤0.01%	5340
2025 Q4	$1.99K	Buy	19 +12	+171%	+$1.02K	﹤0.01%	4694
2025 Q3	$439	Buy	7 +4	+133%	+$178	﹤0.01%	4573
2025 Q2	$68	Buy	+3	New	+$70	﹤0.01%	4348

Other funds holding PVLA

SWM

Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return

Farther Finance Advisors's PVLA Position: Q2 2026 in Review

Farther Finance Advisors increased its Palvella Therapeutics (PVLA) stake by 333% in Q2 2026, buying an estimated $1.21K and bringing the position to 13 shares worth $1.99K. The position accounts for ﹤0.01% of the portfolio, ranked #5171.

Farther Finance Advisors first reported a position in PVLA in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.99K in Q4 2025. 5 funds tracked by Wall St. Rank hold PVLA as of Q2 2026.

Farther Finance Advisors held 13 shares of Palvella Therapeutics worth $1.99K as of Q2 2026.
Farther Finance Advisors bought 10 Palvella Therapeutics shares in Q2 2026, an estimated $1.21K.
Palvella Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5171 holding.
Farther Finance Advisors first reported a position in Palvella Therapeutics in Q2 2025 and has held it in 5 quarters since.
Farther Finance Advisors's Palvella Therapeutics position peaked at $1.99K in Q4 2025.
5 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.